Sesen Bio nears a five year high ahead of key FDA decision on cancer drug
Grandbrothers/iStock Editorial via Getty Images
- Sesen Bio (SESN +22.0%
) has added over a fifth to the market capitalization as shares reached the highest level since September 2016 on above-average volume ahead of a key milestone for the clinical-stage…
